logo
Campaigner fears longer waits between smear tests could 'cost lives'

Campaigner fears longer waits between smear tests could 'cost lives'

Yahoo01-07-2025
'WE can't afford to take a step backwards' – a Warrington woman is pushing back against longer waits between cervical screenings that could 'cost lives'.
Leanne Jones, who lives in Padgate, was scrolling on her phone when she came across a social media post from Warrington and Halton Hospitals Trust.
This post shared the announcement from the NHS that cervical screenings for women aged 25 to 49 will now be every five years for those who test negative for HPV, starting in July.
Cervical screenings, also known as smear tests, is a test to prevent cancer which takes a sample of cells from the cervix.
Women between the ages of 25 and 49 are currently invited to have a screening every three years if 'high risk' HPV's are not found in the cells.
Leanne, 37, is someone who has to attend smear tests more regularly after an abnormality was found at a screening, and she is also someone who lost a family member to cervical cancer.
She now feels that the five-year gap between appointments could leave more women at risk of developing cancer.
'It just doesn't seem right,' she said.
'It's played on my mind ever since because I have to go every six months for check ups. This is something that has happened over the last two years after never having any issues before.
'My personal experience has shown there can be a lot of changes in a two-year period.'
Leanne (left) feels the gap between tests could mean cancer is left undetected for longer (Image: Supplied)
Leanne's family member had her screening delayed by Covid, which meant any abnormalities went undetected for longer. Sadly, she died at just 40 years old.
'She went through hell,' said Leanne.
'It was horrendous. She was a young woman with kids to leave behind and it could have been avoided.
'A delay is a delay – whether it's caused by Covid or a longer wait between appointments.'
For many women, smear tests can be intimidating and Leanne believes that extending the wait between appointments only exacerbates the nerves women may feel, and may mean some decide not to go at all.
'It's a scary thing, for so many women,' she said.
'When you go more frequently, it does make it less daunting.
'But, if it's less frequent, then it does make it look less important – people might think 'I just won't go at all'.'
Despite her concerns, Leanne does think that there have been great steps taken by the NHS to help prevent cervical cancer, such as the HPV vaccine.
However, she feels this progress is negated by the increase of time between appointments, calling it 'mixed messages'.
'I can't find one person that thinks it's a good idea,' she said.
'There are still women dying every year from cervical cancer. They've not cured it.
'They've obviously done a lot with the HPV vaccine, so they're doing a lot of positive things. But I feel while there's still people who haven't had the vaccine and there's still variables to it seems too soon to jump to five years.
'Everybody I speak to seems to have the same opinion - that it's going to cost lives by risking those longer intervals.'
Read more
Mobile clinic to offer cervical screening tests in Warrington
Boyfriend, dad and friends of woman who fought cancer twice team up for big challenge
New £11 million health centre that aims to reduce waiting times has officially opened
Leanne has now launched a petition on Change.org to try and reverse this decision.
'We cannot afford to take a step backwards in women's healthcare,' she said.
'My story can't be unique. It can't just be me and my loved one that have had these experiences.
'I don't think my petition is going to change the world, but I've got nothing to lose by trying and by talking about because there are people who aren't here to talk about it themselves.'
The change will commence tomorrow, Tuesday, and has followed a recommendation by the UK National Screening Committee, and it is already the approach used for women aged 50 to 64 in England.
Those whose sample indicated the presence of HPV, or have had a recement history of HPV, will continue to be invited to more frequent screenings.
Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need.
'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments.
'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Akari Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
Akari Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference

Yahoo

time25 minutes ago

  • Yahoo

Akari Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference

Video webcast now available on-demand BOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced Abizer Gaslightwala, Director, President and Chief Executive Officer of Akari, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. As part of the event, Mr. Gaslightwala dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's programs in development. The on-demand video webcast is now available on as well as the Presentations page in the Investors section of the Company's website ( About Akari Therapeutics Akari Therapeutics is an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs). The Company has developed its first novel payload, PH1, a spliceosome inhibitor designed to disrupt RNA splicing within cells. PH1 is highly differentiated in its mechanism of action against cancer cells from current ADC payloads that use Topoisomerase1 inhibitors or tubulin inhibitors. This splicing inhibition has been shown in preclinical animal models to induce cancer cell death while activating immune cells to drive robust and durable activity. Using this novel payload, Akari has the ability to generate multiple ADC molecules based on the desired application to a range of cancer targets of interest. Akari's lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and delivers its novel PH1 payload directly into the tumor. In preclinical studies, AKTX-101 has shown to have significant activity and prolonged survival, relative to ADCs with traditional payloads. Additionally, AKTX-101 has the potential to be synergistic with checkpoint inhibitors and has demonstrated prolonged survival as both a single agent and in combination with checkpoint inhibitors, as compared to appropriate controls. The Company is generating validating data on its novel payload PH1 to continue advancing its lead asset, as well as other undisclosed targets with this novel payload. For more information about the Company, please visit and connect on X and LinkedIn. Investor Relations Contact JTC Team, LLC Jenene Thomas 908-824-0775 AKTX@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Can A Chatbot Be Your Therapist? Casper's Neil Parikh Launches A New $93 Million Startup To Try
Can A Chatbot Be Your Therapist? Casper's Neil Parikh Launches A New $93 Million Startup To Try

Forbes

time28 minutes ago

  • Forbes

Can A Chatbot Be Your Therapist? Casper's Neil Parikh Launches A New $93 Million Startup To Try

Daniel Cahn (left) and Neil Parikh (right), cofounders of Slingshot AI. courtesy of slingshot N eil Parikh's first startup Casper made sleep easy—and even cool. The med school dropout used tech to help people buy mattresses with just a few clicks. Now he wants to make getting therapy just as simple. After turning the sleep brand into a billion-dollar business, the Forbes Under 30 alum is back with a new venture: Slingshot AI, a startup building a chatbot designed to replicate the experience of talking to a therapist. 'I never really thought about therapy,' Parikh told Forbes . 'Then I found a therapist who changed my life.' That's how it clicked for the entrepreneur. While millions struggle with mental health issues, access to care is staggeringly limited. 'We realized there's over 10,000 people who want care for every therapist that's out there,' he said. 'There was an opportunity for AI to actually help people in a new way.' On Tuesday, Slingshot officially launched its AI-powered therapy bot, called Ash, and announced a follow-on Series A round co-led by Radical Ventures and Forerunner Ventures, with participation from existing investors Andreessen Horowitz, Menlo Ventures and others. The round brings Slingshot's total funding to $93 million as it emerges from beta after being tested with more than 50,000 users. Parikh founded the startup with Daniel Cahn, a machine learning engineer who previously worked on AI tools for mental health in the UK. Unlike general purpose models like ChatGPT—which pull data from the internet—Ash was developed in collaboration with clinicians and trained specifically on behavioral health data. It doesn't offer advice or try to diagnose, but is instead designed to guide users more through self-reflection, similar to how a therapist might prompt deeper thinking. Andreessen Horowitz's a16z was quick to back the entrepreneur. Daisy Wolf, partner at the firm, said they'd been actively looking for a startup bringing AI into the mental health space, handing Slingshot a term sheet as soon as the team was ready to raise. 'They have the experience and know how to pull this off. They've been absolute magnets for talent, and the caliber of people they've been able to recruit has continued to blow us away,' Wolf said. Parikh was 22 when he dropped out of medical school to build Casper. The company wasn't the first to sell mattresses online, but it was the first to become a household name with mattress-in-a-box convenience and a wellness-focused message that turned sleep into a lifestyle. Celebrity endorsements and subway ads helped build the brand amongst a younger audience. Parikh went all in and even co-authored a book on sleep. Casper went public in 2020 at $12 a share—below its target range—and returned to private ownership two years later. He stepped down in 2021 and fully exited the board after the sale. Since then, he's invested in more than 150 startups, many tied to mental health. Now back in the founder seat, he says building from the ground up is both daunting and exciting. 'Every part of this business is really challenging when you think about it. You have to build a large scale data set through partnerships. You have to build a team that knows how to train AI models. You actually have to learn how to train the models,' he said. The burning question: Can a chatbot really compare to a human therapist? Though the concept of AI therapy might seem experimental, early evidence suggests it could have real potential. At Dartmouth College, researchers developed and tested their own chatbot therapist called Therabot. In a trial of more than 100 people with mental health conditions, all improved. Those with depression saw a 51% symptom drop on average. Nicholas Jacobson, one of the clinicians behind Therabot, said chatbots can offer several advantages over traditional care, including cost, convenience and 24/7 availability. Even individuals who had not previously responded to therapy saw significant improvement with Therabot. "A full caseload is about 26-and-a-half patients a week for a practicing therapist,' he said. 'They will see their patients generally once a week in outpatient settings for about 45 minutes.' In that case, why not use the widely popular generative AI models like ChatGPT or Google's Gemini? While these models are incredibly advanced, they aren't designed specifically for mental health care, Jacobson said, and can be potentially harmful. At Dartmouth, this meant researchers had to build their own data from scratch. At Slingshot, it means partnering directly with clinicians—and using that $93 million to build a better data pipeline. And, Parikh adds, general models can be somewhat of yes-men. 'You want them to appropriately push back on you. That's a core part of self growth.' Courtesy of Slingshot Still, not everyone is convinced chatbots can handle mental health responsibly. Critics have raised concerns about safety and privacy. Slingshot says it's proactively addressing these issues by working with a clinical advisory board. Ash, for example, redirects users experiencing a serious crisis to human professionals. This time around, the serial entrepreneur (who's gone to plenty of therapy since) wants to keep the company lean and mission-driven. For its initial launch, Ash will be available for free to users, and Parikh imagines rolling out a subscription model priced similarly to Netflix. In the future, there may be avenues for Ash to be available via employers or insurance. In the meantime, Parikh says he isn't trying to reinvent therapy, but hoping Ash might just help more people start it. 'Doing anything that nobody's done before means that you have to figure out a lot of new things,' he said. 'It's a lot of unknown nodes, but it's also cool because every day we get to wake up and get feedback from people who say this is incredible and their lives changed.'

Row over NHS doctor strike deepens as poll suggests public support is waning
Row over NHS doctor strike deepens as poll suggests public support is waning

Yahoo

timean hour ago

  • Yahoo

Row over NHS doctor strike deepens as poll suggests public support is waning

The row between the British Medical Association (BMA) and health leaders over the upcoming doctor strike has deepened as research suggests public support for the action is waning. NHS Providers, which represents hospital trusts, hit back at BMA claims that health leaders were putting patients at risk, saying it was actually the 'costly' BMA strike that was risking patient care. It comes as Health Secretary Wes Streeting told the House of Commons he 'sincerely hopes the BMA will postpone' the 'unnecessary and irresponsible' strikes to continue talks with the Government, which he said had been 'constructive' in recent days. He said, however, the Government stands 'ready' and 'responsive' if the five-day strike by resident doctors, which is scheduled to start at 7am on Friday, does go ahead. Earlier, the BMA said NHS England plans for managing the strike could put patients at risk owing to the fact it has ordered hospitals to continue with as much pre-planned care as possible. We've written to NHS England with concerns about inadequate planning ahead of possible strike action later this week. Attempts to run non-urgent services with fewer doctors risk patient safety. It's imperative that Trusts postpone work to protect urgent and emergency care. — The BMA (@TheBMA) July 21, 2025 Previous strikes by health workers have seen hundreds of thousands of operations and appointments cancelled, but NHS England is taking a different approach this time to managing the strike. In a letter to hospital trust leaders, it urges the health system to focus on maintaining emergency care, maintaining the flow of patients and 'maintaining elective care to the fullest extent possible' as well as 'priority treatments' such as cancer care. 'It will be important for systems and trusts to try and maintain normal levels of booked activity…' it said, adding: 'Reducing volumes of bookings and rescheduling of appointments and other activity should only happen in exceptional circumstances to safeguard patient safety.' On Tuesday morning, BMA deputy chairwoman Dr Emma Runswick told BBC Radio 4's Today programme this plan risked patient safety. She said: 'We've had proven systems over the last decade that have made sure that where we have to take strike action, senior doctors cover urgency and critical care. 'This time round, NHS England are pushing for the continuation of non-urgent and scheduled care in a way that we think at best is confusing and will create on-the-day cancellations – and at worst could be risky and lead to harm in emergency departments and on wards, because senior doctors cannot physically be in two places at once. 'We think that a notional guidance from NHS England which is saying that basically all scheduled work should continue to go ahead has potential to be seriously risky for patients… 'Senior doctors are needed to be freed up in order to provide urgency and critical care. 'We think the vast majority of planned and unscheduled care should be shifted.' NHS Providers hit back at the BMA's claims, saying it was the strike itself that posed a risk to patients. Its chief executive, Daniel Elkeles, said: 'The NHS, not the BMA, is putting patients' interests first. 'Given that some patients will be caused undoubted harm if the short-notice strike goes ahead, NHS trusts are doing the responsible thing by not cancelling people's care while talks to avert the strike are ongoing. 'Now is a time for cool heads in the BMA because it's not too late to avoid a damaging, costly strike. NHS trust leaders hope for a breakthrough from talks between Government and the union. 'If the strike goes ahead then NHS trusts will do everything they can to avoid any harm to patients and are planning for as many patients as possible to be cared for.' It comes as a new YouGov poll showed about half (52%) of people in the UK either 'somewhat oppose' (20%) or 'strongly oppose' (32%) the idea of resident doctors going on strike over pay. Meanwhile, a third (34%) of the 4,954 adults surveyed either 'somewhat support' (23%) or 'strongly support' (11%) doctor strikes. YouGov said the proportion supporting the strike over pay has dropped five points since it last asked the question in May. Then, 48% opposed resident doctors striking, while 39% supported them taking action. Speaking in the Commons on Tuesday, Mr Streeting said that before he came into office, 'strikes were crippling the NHS'. He added: 'Costs ran to £1.7 billion in just one year, and patients saw 1.5 million appointments rescheduled. 'Strikes this week are not inevitable, and I sincerely hope the BMA will postpone this action to continue the constructive talks my team and I have had with them in recent days. 'Regardless, our priority is to keep patients safe, and we will do everything we can to mitigate the impacts of strikes on patients and the disruption that will follow should these totally unnecessary and avoidable strikes go ahead.' Quizzed by MPs, he said the 'approach we're taking is different from that taken in previous periods of strike action'. He added: 'NHS leaders have been clear to me that previous rounds of strike action caused much wider levels of harm than previously realised, and there is no reason why planned care in issues like cancer, for example, cancer appointments, as well as other conditions should be treated as somehow less important or second fiddle to other NHS services. 'That is why the chief executive of NHS England has written to NHS leaders asking them to keep routine operations going to the fullest extent possible, as well as continuing priority treatments. 'It will be for local leaders to determine what's possible given staffing levels. 'That's why it's really important that resident doctors do engage with their employers about their determination or not to turn up at work this week, and why again, I just spell out the serious consequences for patients that means that these avoidable and unnecessary strikes should not go ahead.' Consultants and SAS doctors in England – look out for your indicative ballot email from @TheBMA today! Wes Streeting called pay restoration "a journey, not an event" – so why have we stopped? Are you prepared to stand up to demand your value is recognised by the government? — Tom Dolphin🏳️‍🌈 🏳️‍⚧️ (@thomasdolphin) July 21, 2025 Elsewhere, the BMA has also issued strike guidance for consultants regarding the extra pay they can seek for covering work that is not in their contracts. The BMA 'rate card' says consultants can ask for £188 per hour on weekdays from 7am-7pm and £250 an hour from 7pm to 11pm. At weekends, the pay claim can rise to £250 per hour from 7am to 11am and £313 per hour for overnight work from 11pm to 7am. Resident doctors, formerly known as junior doctors, were awarded an average 5.4% pay increase this financial year, following a 22% rise over the previous two years. However, the BMA says real-terms pay has still fallen by around 20% since 2008, and is pushing for full 'pay restoration'. Resident doctors are qualified doctors in clinical training. They have completed a medical degree and can have up to nine years of working experience as a hospital doctor, depending on their specialty, or up to five years of working and gaining experience to become a GP.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store